Skip to main content
© Cliniphai. All rights reserved.

Cliniphai and Gibson Research Consultancy Partner to Streamline Global COA and eCOA Translation Workflows

GREAT FALLS, Montana and LONDON (September 9, 2025) — Cliniphai, an AI Agent and Framework platform purpose-built to solve complex challenges in life sciences, announced a strategic partnership with Gibson Research Consultancy (GRC), a global leader in health communication, patient voice research, linguistic validation and patient-centered research for Clinical Outcome Assessments (COA and eCOA) and other related health information and patient-facing documents. The partnership brings together GRC’s world-class expertise and Cliniphai’s AI-powered Athena™ platform to redefine how translation and localization services are delivered across clinical trials.

Cliniphai, an AI Agent and Framework platform purpose-built to solve complex challenges in life sciences, announced a strategic partnership with Gibson Research Consultancy (GRC), a global leader in health communication, patient voice research, linguistic validation and patient-centered research for Clinical Outcome Assessments (COA and eCOA) and other related health information and patient-facing documents. The partnership brings together GRC’s world-class expertise and Cliniphai’s AI-powered Athena™ platform to redefine how translation and localization services are delivered across clinical trials.

GRC has provided services for nearly every top pharmaceutical company, with over 11,000 COA and eCOA validation projects completed across more than 250 languages and more than 190 countries and territories. Under this new collaboration, GRC will perform its full suite of linguistic validation services directly through Cliniphai’s Athena platform.

Work has already begun, with GRC teams actively managing studies through Athena’s centralized environment. The platform enables project visibility, version tracking, ISPOR-compliant workflows, and integrated QA monitoring to provide both service providers and sponsors with greater control and confidence across timelines and geographies.

“This partnership is the clearest signal yet of how AI can support trusted experts in delivering global outcomes,” said Jason Martin, MS, MBA, Chairman and Co-Founder at Cliniphai. “GRC has set the global standard for COA translation excellence, and Athena provides the tools they need to deliver at scale with structure, speed, and quality.”

Delivering clinical translations at scale pharma and biotech

Athena is Cliniphai’s flagship AI-powered platform for clinical translation and localization, now operating as a marketplace model to support collaboration across sponsors, eCOA providers, freelance language experts, and reviewers. The platform is purpose-built for life sciences and delivers:

  • AI-assisted clinical translation workflows with human-in-the-loop steering
  • Adaptive, context-aware translation with support for dialects and terminology control
  • Centralized version tracking, QA checkpoints, and real-time progress visibility
  • Built-in ISPOR-compliant workflows and automated Certificate of Translation support
  • Seamless integration with existing systems through secure APIs
  • Flexible private cloud solutions designed to align with customer-specific security, infrastructure, and compliance standards
  • Marketplace functionality to connect clinical teams with qualified language professionals
  • Operational transparency and structured collaboration across global study teams

“The first time I saw Athena, I recognized its potential immediately,” said Mark Gibson, MA, Founder, GRC. “Cliniphai created something original that brings clarity and structure to clinical translation workflows in a way we had not seen before. I am proud to partner with a team that understands the importance of both innovation and execution in this space.”

Athena is designed to reduce delays, eliminate manual tracking, and support accurate, compliant translations across every phase of clinical development. To explore Athena’s marketplace model or work with the team, visit https://cliniphai.com/solutions/athena/.

About Cliniphai

Cliniphai is an AI Agent and Framework platform purpose-built to solve complex challenges in life sciences. Its flagship solution, Athena, is a marketplace-driven platform for clinical translation and localization that combines AI-powered workflows with built-in compliance and operational transparency. Designed to support sponsors, CROs, eCOA providers, and language experts alike, Athena enables secure, scalable, and collaborative execution across global studies. For more, visit www.cliniphai.com.

About Gibson Research Consultancy (GRC)

Founded in 2008 by Mark Gibson, GRC is a global leader in health communication, patient voice research, linguistic validation and patient-centered research for COA and eCOA and other related health information and patient-facing documents. Based in Leeds, United Kingdom, GRC supports multi-country studies across more than 250 languages through a trusted network of regulatory, linguistic, and research partners. The team brings more than two decades of experience in qualitative research and multilingual testing, with a proven ability to complete projects in rarer, creole, minority, and indigenous languages. GRC’s commitment to clarity, accuracy, and user relevance has made it a trusted partner to nearly every top pharmaceutical company worldwide. For more, visit: https://www.grc-health.com/.

Media Contacts

Don F. McLean, McLean Media
+1-734-716-4162

###

Cliniphai Unveils Marketplace Model for Athena Clinical Translation and Localization Platform at BIO 2025 in Boston, Company Appoints Michael Arbitman as Executive Chief of Staff to Accelerate Platform Execution

Cliniphai, an AI Agent and Framework platform purpose-built to solve complex challenges in life sciences, today announced the next phase of its flagship platform, Athena, at the BIO International Convention 2025. Building on the powerful workbench for clinical trial localization, Athena expands its services to create a total marketplace model designed to connect eCOA providers, translation freelancers, and clinical trial sponsors, among numerous others, in a unified ecosystem.

This evolution transforms Athena from a standalone solution into a connected platform where compliance, efficiency, global collaboration, and scalable execution converge. By aligning AI workflows with regulatory standards and integrating end-to-end tracking, Athena delivers a seamless, transparent experience that accelerates multilingual clinical trial operations.

“This update is a step forward for how regulated translation can operate in the clinical research industry overall,” said Jason Martin, MS, MBA, Chairman and Co-Founder at Cliniphai. “Athena now brings translators, reviewers, and life sciences teams into one connected system. It’s a smarter model that supports better outcomes across global studies.”

Athena’s new marketplace allows organizations to:

  • Engage qualified translation experts within the platform
  • Track version history and QA across language pairs
  • Maintain ISPOR-compliant workflows with built-in checkpoints
  • Eliminate vendor threads and siloed document tracking
  • Accelerate time-to-launch for global studies with flexible engagement options

The platform is built to support the real-world needs of eCOA vendors managing multilingual content, sponsors navigating global submissions, and qualified translators seeking structured, high-value work in regulated settings.

Leadership growth continues at Cliniphai

To support this next chapter, Cliniphai has appointed Michael Arbitman as Executive Chief of Staff. Formerly a top-level executive with Medidata, CARET Legal, and Fresh Direct, Arbitman brings decades of experience in product strategy, FDA-regulated systems, and Agile program delivery, and will lead execution across Athena’s growing marketplace environment

“I see a clear opportunity to help shape the future of Athena by building a strong operating model that supports global scale and regulatory clarity,” said Arbitman. “It’s a privilege to lead this work alongside a team that brings deep scientific and clinical expertise to every part of the platform.”

Arbitman is already leading implementation efforts on Athena for major global translation projects, including managing ISPOR-compliant Morisky Medication Adherence Scale (MMAS) workflows across five language pairs, country-specific PI reviewer coordination, and real-time QA reporting.

Cliniphai’s team will be at booth 1269 during BIO 2025 in Boston, connecting with partners across the translation, eCOA, and clinical technology space. To explore Athena’s marketplace model or speak with the team, visit www.cliniphai.com.

About Cliniphai

Cliniphai is an AI Agent and Framework platform purpose-built to solve complex challenges in life sciences. Its flagship solution, Athena, is a marketplace-driven platform for clinical translation and localization that combines AI-powered workflows with built-in compliance and operational transparency. Designed to support sponsors, eCOA providers, and language experts alike, Athena enables secure, scalable, and collaborative execution across global studies. For more, visit www.cliniphai.com.

Media Contacts

Don F. McLean, McLean Media
+1-734-716-4162

###